Conflicts of interest E.S. has acted as a paid consultant to Meda, Mavig, Almirall, Spirig, Heidelberg Pharma, Intendis and has received funding for research carried out in his work. C.U. has acted as a paid consultant to Almirall, Spirig, Novartis, Wyeth and has received funding for research carried out in his work. D.T. and U.D. declare no conflicts of interest.
Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure
Version of Record online: 22 SEP 2009
© 2009 The Authors. Journal Compilation © 2009 British Association of Dermatologists
British Journal of Dermatology
Special Issue: Advances in the Management of UVR induced Skin Cancers.
Volume 161, Issue Supplement s3, pages 85–89, November 2009
How to Cite
Terhorst, D., Drecoll, U., Stockfleth, E. and Ulrich, C. (2009), Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. British Journal of Dermatology, 161: 85–89. doi: 10.1111/j.1365-2133.2009.09454.x
- Issue online: 22 SEP 2009
- Version of Record online: 22 SEP 2009
- Accepted for publication 7 August 2009
- organ transplant;
- risk factor;
- skin cancer;
- sun exposure
Background Organ transplant recipients (OTRs) have an increased risk of developing skin cancer, especially epithelial tumours. A number of factors such as immunosuppression, age, ultraviolet radiation and skin type are considered as important in aetiology.
Objectives The purpose of this study was to further evaluate the risk factors for OTRs regarding skin cancer after transplantation. A detailed investigation of the specific compounds of sun exposure was realised.
Methods A questionnaire-based study was performed in a specialist OTR dermatology clinic from January to April 2009. The subjects were 70 organ transplanted patients who had developed some form of skin cancer after transplantation. As controls served 69 organ transplanted patients who had no history of skin cancer. The controls were matched concerning age, transplanted organ and gender. Photo protection, sun exposure and transplantation data were part of the questionnaire. Statistical analysis was performed with Mann–Whitney-U-test, chi-square test or Fisher’s exact test.
Results The total sun burden (TSB) and the recreational sun exposure in particular attained higher scores in the skin cancer group (TSB-score: mean 11·8 vs. 10·0, P < 0·05; recreational sun exposure: mean 6·3 vs. 5·1, P < 0·05). The skin cancer group had fairer skin types than the control group (median skin type 2 vs. 3, P < 0·05). The OTRs who developed skin cancer have been more likely to have a history or present intake of azathioprine (mean 42% vs. 21%, P < 0·05). Also, the skin cancer group has been transplanted for a longer time (mean 12·3 vs. 7·2 years, P < 0·001), analogously had a younger age at transplantation (mean 49·5 vs. 52·7 years, P < 0·001).
Conclusions Recreational sun exposure is of central importance for OTRs. A long period of transplantation and thus immunosuppression presents a main risk factor for the development of skin cancer in OTRs. A multi disciplinary management with the best medication and a focus on sun protection is needed to prevent skin cancer in OTRs.